Literature DB >> 20929385

Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences.

Delaram Sayadpour Zanjani1, Majid Shahabi, Nasim Talaei, Monavar Afzalaghaee, Farahnaz Tehranian, Reihane Bazargani.   

Abstract

Human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) Western blot indeterminate results are a problem for blood banks in endemic areas. To determine the prevalence of HTLV-1/2 infection among indeterminate donors, we analyzed 130 cases from Mashhad, an HTLV-1/2 endemic area in Northeast Iran. The most frequent Western blot bands were GD21 alone (37.2%) followed by rgp46-2 alone (32.1%). We further tested 40 available DNA samples of these cases by PCR for viral sequences, tax, gag, and pol, and found five cases (12.5%) to be positive for two or three HTLV-1 genes. There were no significant age, sex, and blood group differences between PCR-positive and PCR-negative cases. Among PCR-positive individuals, the most prevalent Western blot bands were variable combinations of rgp46-1, GD21, and gp21. The mean of the optical density (OD) of the enzyme-linked immunosorbent assay (ELISA) test was significantly higher in PCR-positive individuals. The frequency of the rgp46-1 band was also significantly higher in PCR-positive cases compared to PCR-negative ones. In conclusion, the majority of HTLV-indeterminate donors lack the HTLV provirus and therefore are not considered infected. However, in some cases with higher ODs in the ELISA test and seroreactivity to env proteins, rgp46-1 and GD21 in particular may be indicative of infection and need further evaluation by molecular methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20929385     DOI: 10.1089/aid.2010.0017

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1.

Authors:  Madoka Kuramitsu; Kazu Okuma; Makoto Yamagishi; Tadanori Yamochi; Sanaz Firouzi; Haruka Momose; Takuo Mizukami; Kazuya Takizawa; Kumiko Araki; Kazuo Sugamura; Kazunari Yamaguchi; Toshiki Watanabe; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

Review 4.  Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam; Reza Jafarzadeh Esfehani; Hiba El Hajj; Ali Bazarbachi
Journal:  Viruses       Date:  2022-03-23       Impact factor: 5.818

Review 5.  The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.

Authors:  Anna Abrams; Yoshimi Akahata; Steven Jacobson
Journal:  Viruses       Date:  2011-08-02       Impact factor: 5.048

6.  Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.

Authors:  Karoline R Campos; Fred L N Santos; Bernardo Galvão-Castro; Adele Caterino-de-Araujo; Vanessa da Silva Brito; Noilson L S Gonçalves; Thessika H A Araujo
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

7.  No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran.

Authors:  Houshang Rafatpanah; Farhad Fathimoghadam; Majid Shahabi; Iman Eftekharzadeh; Mohammadreza Hedayati-Moghaddam; Narges Valizadeh; Mohsen Tadayon; Seyyed Aliakbar Shamsian; Hamidreza Bidkhori; Raheleh Miri; Ali Bazarbachi
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 8.  A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

9.  Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Authors:  Kazu Okuma; Madoka Kuramitsu; Toshihiro Niwa; Tomokuni Taniguchi; Yumiko Masaki; Gohzoh Ueda; Chieko Matsumoto; Rieko Sobata; Yasuko Sagara; Hitomi Nakamura; Masahiro Satake; Kiyonori Miura; Naoki Fuchi; Hideaki Masuzaki; Akihiko Okayama; Kazumi Umeki; Yoshihisa Yamano; Tomoo Sato; Masako Iwanaga; Kaoru Uchimaru; Makoto Nakashima; Atae Utsunomiya; Ryuji Kubota; Kenji Ishitsuka; Hiroo Hasegawa; Daisuke Sasaki; Ki-Ryang Koh; Mai Taki; Kisato Nosaka; Masao Ogata; Isao Naruse; Noriaki Kaneko; Sara Okajima; Kenta Tezuka; Emi Ikebe; Sahoko Matsuoka; Kazuo Itabashi; Shigeru Saito; Toshiki Watanabe; Isao Hamaguchi
Journal:  Retrovirology       Date:  2020-08-24       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.